Talazoparib trials for Breast cancer

All Talazoparib trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Talazoparib for Breast cancer

• Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
  NCT03990896 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test
  NCT06193525 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
  NCT05035745 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Talazoparib for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.